Clinical Trial Update: 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 clinical trial is testing topical 5-fluorouracil in combination with calcipotriene for superficial basal cell carcinoma and squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Squamous Cell Carcinoma in Situ

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Calcipotriene (calcipotriene)

Snippet

Sponsor: Boston University | Conditions: Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ | Phase 2, Phase 3 | Status: RECRUITING